Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005045 · ClinicalTrials.gov registry record · Phase 2
Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
A Phase 2 study of Kidney Cancer, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
NCT00005045: Completed Phase 2 study of Kidney Cancer, sponsored by Eastern Cooperative Oncology Group.
NCT00005045 is a Phase 2 study of Kidney Cancer that has completed, run by Eastern Cooperative Oncology Group. The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005045, a Phase 2 study of Kidney Cancer, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of carboxyamidotriazole in treating patients who have advanced kidney cancer that has not responded to biological therapy.
Conditions Studied
Interventions
- DRUG carboxyamidotriazole
Study Locations (20)
Florida
- Veterans Affairs Medical Center - Gainsville - Gainesville
- Sylvester Cancer Center, University of Miami - Miami
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
- Veterans Affairs Medical Center - Tampa (Haley) - Tampa
California
- Beckman Research Institute, City of Hope - Los Angeles
- Veterans Affairs Medical Center - Palo Alto - Palo Alto
- Stanford University Medical Center - Stanford
Iowa
- CCOP - Cedar Rapids Oncology Project - Cedar Rapids
- CCOP - Iowa Oncology Research Association - Des Moines
- University of Iowa Hospitals and Clinics - Iowa City
Georgia
- Emory University Hospital - Atlanta - Atlanta
- Veterans Affairs Medical Center - Atlanta (Decatur) - Decatur
Illinois
- CCOP - Evanston - Evanston
- CCOP - Illinois Oncology Research Association - Peoria
Indiana
- Indiana University Cancer Center - Indianapolis
- Veterans Affairs Medical Center - Indianapolis (Roudebush) - Indianapolis
Arizona
- CCOP - Scottsdale Oncology Program - Scottsdale
Colorado
- CCOP - Colorado Cancer Research Program, Inc. - Denver
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-03 |
| Est. Completion | 2004-06 |
| Phase | Phase 2 |
What the finished NCT00005045 record still lists
NCT00005045 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 1 intervention - of which carboxyamidotriazole is the first listed.
NCT00005045 names 20 study sites across 10 states, led by Florida, California, Iowa.
Frequently Asked Questions
What is clinical trial NCT00005045 about?
NCT00005045 is a clinical study titled "Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer". RATIONALE: Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of carboxyamidotriazole in treating patients who have advanced kidney cancer that has not responded to biological therapy.
What is the current status of trial NCT00005045?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-03. Estimated completion is 2004-06.
What conditions does trial NCT00005045 study?
This clinical trial studies the following conditions: Kidney Cancer.
What interventions are being tested in trial NCT00005045?
The interventions under investigation include: carboxyamidotriazole (DRUG).
Who is sponsoring clinical trial NCT00005045?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005045 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Delaware, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
RECRUITING · Phase 2
-
NSAID Use After Robotic Partial Nephrectomy
RECRUITING · Phase 2
-
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
RECRUITING · Phase 2
-
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
RECRUITING · Phase 2
-
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
RECRUITING · Phase 2
-
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia